Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03819088 · ClinicalTrials.gov registry record · NA
Effects on Quality of Life With Zinc Supplementation in Patients With Gastrointestinal Cancer
A NA study, sponsored by Emory University.
- Completed
- Registry status
- NA
- Development phase
- 17
- Enrollment target
NCT03819088 is a NA study that has completed, run by Emory University. The registered enrollment target is 17 participants.
The verdict
NCT03819088, a NA study, has completed, sponsored by Emory University.
- COMPLETED
- Registry status
- NA
- Development phase
- 17 participants
- Enrollment target
Study Summary
This randomized study examines how well zinc works in improving quality of life in patients with gastrointestinal cancer that cannot be removed by surgery who are receiving chemotherapy. Zinc may help to improve patient's quality of life by preventing zinc deficiency.
Interventions
- DIETARY_SUPPLEMENT Zinc
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17 participants |
| Start Date | 2019-04-17 |
| Est. Completion | 2022-03-22 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03819088
The ClinicalTrials.gov registry entry for NCT03819088 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 17 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Zinc is the first listed.
NCT03819088 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03819088 about?
NCT03819088 is a clinical study titled "Effects on Quality of Life With Zinc Supplementation in Patients With Gastrointestinal Cancer". This randomized study examines how well zinc works in improving quality of life in patients with gastrointestinal cancer that cannot be removed by surgery who are receiving chemotherapy. Zinc may help to improve patient's quality of life by preventing zinc deficiency.
What is the current status of trial NCT03819088?
This trial is currently completed. It is a NA study. The enrollment target is 17 participants. The study started on 2019-04-17. Estimated completion is 2022-03-22.
What interventions are being tested in trial NCT03819088?
The interventions under investigation include: Zinc (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT03819088?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.